Rockefeller University

  • In May, the National Center for Accelerating Clinical Translational Science (NCATS) granted a $2.7 Million award to Rockefeller University to develop new infrastructure facilitating collection of research participant feedback for widespread adoption: “Empowering the Participant Voice: Collaborative Infrastructure and Validated Tools for Collecting Participant Feedback to Improve the Clinical
  • The gut is an unusually noisy place, where hundreds of species of bacteria live alongside whatever microbes happen to have hitched a ride in on your lunch. Scientists have long suspected that the gut’s immune system, in the face of so many stimuli, takes an uncharacteristically blunt approach to population control and protection from foreign invaders—churning out non-specific antibodies with broad
  • For people with rheumatoid arthritis, life is a little like sailing. On clear days with no symptoms, everything works exactly as it should; when a storm rolls in and symptoms flare up, even simple tasks become painfully difficult. But while literal storms are easy to forecast, arthritis flares tend to strike with no rhyme or reason.
  • A series of compounds discovered in the laboratory of Rockefeller’s Jan L. Breslow will be developed into novel medicines, the drug discovery company Bridge Medicines recently announced. These compounds have shown promise in treating immune-mediated conditions in animals, such as models of rheumatoid arthritis, without compromising the immune system and harming the rest of the body—a side effect

  • Rockefeller University

    While there is universal recognition of the importance of team science and team leadership in clinical and translational science, there is a remarkable dearth of valid and reliable outcome measures on team science leadership. As a result, we developed a semi-quantitative translational science-specific team leadership competency assessment tool and have begun pilot studies to validate it and use it

  • Drawing of a network on a global

    The New York and Connecticut Consortium encourages joint ventures among the New York and Connecticut area CTSA institutions (NYCON) to develop collaboration between CTSA programs in the areas of medical scientist training; the creation of regional databases of facilities; regional training opportunities for investigators and research coordinators; the exploration of barriers to improved social

  • Rockefeller University
    Clinical Directors Network
    Archived webcasts on a wide range of topics related to clinical and translational science. On Demand Library Sample Titles: An Introduction to Comparative Effectiveness Research (CER 101) The Role of Practice Based Research Networks (PBRNs) Good Clinical Practice: GCP Boot Camp Clinical Scholars Presentations Sample Titles: Skin Cancer and the Future of Novel Optical Imaging Devices Cognitive
  • Image

    The Rockefeller University

    The Rockefeller University mission statement is science for the benefit of humanity. The Rockefeller University Center for Clinical and Translational Science is devoted to maximizing the bidirectional opportunities for clinical and translational research. Building on Rockefeller University Hospital's illustrious history as the birthplace of American biomedical science and translational research, and funded in part by an NIH Center for Clinical and Translational Science Award (CTSA), the Center is designed to provide an optimal infrastructure to conduct clinical and translational research and to educate the next generation of physician scientists committed to patient-oriented research.

    The Center for Clinical and Translational Science continues Rockefeller University's tradition of focusing on the interface between scientific discovery, human pathophysiology, and novel diagnostic, preventative and therapeutic strategies to benefit all of humanity.